Research Paper on:
Trying to Find an AIDS Vaccine That is Effective

Unformatted Sample Text from the Research Paper:
New AIDS cases have declined in the US and several other developed nations, but AIDS is still the scourge of much of Africa, India and China, threatening an  entire generation in some sections of Africa. AIDS was first described in 1981, and researchers have been seeking an effective vaccine for it ever since. Only one candidate  has progressed to advanced trial to date, however. A review of literature combining scientific and business information reveals that it is the business  aspect of the AIDS vaccine that has been most responsible for delay in achieving an effective vaccine. Global health organizations and nonprofit foundations call for greater private sector investment  so that clinical trials of existing formulations can progress. Introduction and Purpose It now has  been more than 20 years since AIDS began to be described and for many of those years researchers have been striving to develop an effective vaccine against the disease that  is being called the scourge of Africa. Efforts to develop an effective vaccine largely have been unsuccessful, but recently the Associate Director of AIDS vaccines at the National Institutes  of Health Margaret Johnston reported that an effective vaccine likely will be available within the next decade (Researchers Say There Will Be An AIDS Vaccine Within 10 Years, 2001).  At the end of 2001, more than 9,000 individuals around the world were participating in clinical trials. This information is optimistic, but the  fact remains that only one potential vaccine has survived through advanced clinical trials to date (Vastag, 2001). Further, the trials themselves involve a great deal of time and it